SILVER SPRING, Md., Jan. 6, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer, and Roger Jeffs, Ph.D., President and Co-Chief Executive Officer, of United Therapeutics will provide an overview and update on the company's business at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, California.
The presentation and the immediately following Q&A breakout session will take place on Monday, January 12, 2015, at 4:00 PM Pacific Standard Time, and can be accessed via a live webcast on the United Therapeutics website at http://www.unither.com under the "Investor" tab in the "Events and Presentations" section. An archived, recorded version of the presentation and the Q&A breakout session will be available approximately twenty-four hours after the Q&A breakout session ends and can be accessed at the same location for 90 days. [uthr-g]
About United Therapeutics
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.
SOURCE United Therapeutics Corporation